clinical search engines, related to pain and analgesia, agitation and sedation, delirium, and related clinical outcomes in adult ICU patients. The group also used psychometric analyses to evaluate and compare pain, agitation/sedation, and delirium assessment tools. All task force members were allowed to review the literature supporting each statement and recommendation and provided feedback to the subcommittees. Group consensus was achieved for all statements and recommendations using the nominal group technique and the modified Delphi method, with anonymous voting by all task force members using E-Survey (www.esurvey.com). All voting was completed in December 2010. Relevant studies published after this date and prior to publication of these guidelines were referenced in the text. The quality of evidence for each statement and recommendation was ranked as high (A), moderate (B), or low/ very low (C). The strength of recommendations was ranked as strong (1) or weak (2) and either in favor of (+) or against (-) an intervention. A strong recommendation (either for or against) indicated that the intervention's desirable effects either clearly outweighed its undesirable effects (risks, burdens, and costs) or it did not. For all strong recommendations, the phrase "We recommend . . . " is used throughout. A weak recommendation, either for or against an intervention, indicated that the tradeoff between desirable and undesirable effects was less clear. For all weak recommendations, the phrase "We suggest . . . " is used throughout. In the absence of sufficient evidence, or when group consensus could not be achieved, no recommendation (0) was made. Consensus based on expert opinion was not used as a substitute for a lack of evidence. A consistent method for addressing potential conflicts of interest was followed if task force members were coauthors of related research. The development of this guideline was independent of any industry funding. Conclusion. These guidelines provide a roadmap for developing integrated, evidence-based, and patient-centered protocols for preventing and treating pain, agitation, and delirium in critically ill patients. Am J Health-Syst Pharm. 2013; 70:53-8 staff of Critical Care Medicine, will be published in the January issue of Critical Care Medicine.
Supporting organizations include the American College of Critical Care Medicine (ACCM) in conjunction with the Society of Critical Care Medicine (SCCM) and the American Society of Health-System Pharmacists (ASHP).
To minimize the perception of bias in these guidelines, individual task force members with a significant conflict of interest on a particular topic were recused from grading the literature, writing evidence summaries, and developing specific statements and recommendations on that topic. Final decisions regarding strength of evidence and strength of recommendations for all questions were voted on anonymously by all task force members.
Mr. Dasta has consultancies with Hospira, Axel Rx, Cadence Pharmaceuticals, and Pacira Pharmaceuticals and has received patients undergoing abdominal aortic aneurysm surgery (+1B). viii. We provide no recommendation for using a lumbar epidural over parenteral opioids for postoperative analgesia in patients undergoing abdominal aortic aneurysm surgery, due to a lack of benefit of epidural over parenteral opioids in this patient population (0,A). ix. We provide no recommendation for the use of thoracic epidural analgesia in patients undergoing either intrathoracic or nonvascular abdominal surgical procedures, due to insufficient and conflicting evidence for this mode of analgesic delivery in these patients (0,B). x. We suggest that thoracic epidural analgesia be considered for patients with traumatic rib fractures (+2B). xi. We provide no recommendation for neuraxial/ regional analgesia over systemic analgesia in med- adult ICU patients at risk of developing delirium, dexmedetomidine infusions administered for sedation may be associated with a lower prevalence of delirium compared to benzodiazepine infusions (B). d. Delirium prevention i. We recommend performing early mobilization of adult ICU patients whenever feasible to reduce the incidence and duration of delirium (+1B). ii. We provide no recommendation for using a pharmacologic delirium prevention protocol in adult ICU patients, as no compelling data demonstrate that this reduces the incidence or duration of delirium in these patients (0,C). iii. We provide no recommendation for using a combined nonpharmacologic and pharmacologic delirium prevention protocol in adult ICU patients, as this has not been shown to reduce the incidence of delirium in these patients (0,C). iv. We do not suggest that either haloperidol or atypical antipsychotics be administered to prevent delirium in adult ICU patients (-2C). v. We provide no recommendation for the use of dexmedetomidine to prevent delirium in adult ICU patients, as there is no compelling evidence regarding its effectiveness in these patients (0,C). e. Delirium treatment i. There is no published evidence that treatment with haloperidol reduces the duration of delirium in adult ICU patients (No Evidence). ii. Atypical antipsychotics may reduce the duration of delirium in adult ICU patients (C). iii. We do not recommend administering rivastigmine to reduce the duration of delirium in ICU patients (-1B). iv. We do not suggest using antipsychotics in pa- Since these guidelines were last published, we have made significant advances in our understanding of how to provide physical and psychological comfort for patients admitted to the intensive care unit (ICU). 1 The development of valid and reliable bedside assessment tools to measure pain, sedation, agitation, and delirium in ICU patients has allowed clinicians to manage patients better and to evaluate outcomes associated with both nonpharmacologic and pharmacologic interventions.
2,3 Our expanded knowledge of the clinical pharmacology of medications commonly administered to treat pain, agitation, and delirium (PAD) in ICU patients has increased our appreciation for both the short-and long-term consequences of prolonged exposure to these agents. [4] [5] [6] We have learned that the methods of administering and titrating these medications can affect patient outcomes as much as drug choice. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] For most ICU patients, a safe and effective strategy that ensures patient comfort while maintaining a light level of sedation is associated with improved clinical outcomes. [9] [10] [11] [12] [13] [16] [17] [18] [19] [20] Ensuring that critically ill patients are free from pain, agitation, anxiety, and delirium at times may conflict with other clinical management goals, such as maintaining cardiopulmonary stability while preserving adequate end-organ perfusion and function. 21, 22 Management goals may be further complicated by the growing number of "evidence-based" bundles and clinical algorithms, some of which have been widely adopted by regulatory agencies and payers. [23] [24] [25] [26] [27] [28] [29] [30] Finally, tremendous worldwide variability in cultural, philosophical, and practice norms and in the availability of manpower and resources makes widespread implementation of evidence-based practices challenging. [31] [32] [33] [34] [35] [36] The goal of these clinical practice guidelines is to recommend best practices for managing PAD to improve clinical outcomes in adult ICU patients. We performed a rigorous, objective, transparent, and unbiased assessment of the relevant published evidence. We balanced this evidence against the values and preferences of ICU patients, family members, caregivers, and payer and regulatory groups and important ICU clinical outcomes to develop relevant statements and recommendations that can be applied at the bedside.
The scope of these guidelines includes short-and long-term management of PAD in both intubated and nonintubated adult medical, surgical, and trauma ICU patients. These guidelines only briefly address the topic of analgesia and sedation for procedures, which is described in more detail in the American Society of Anesthesiologists guidelines on conscious sedation. 37 The American College of Critical Care Medicine is currently developing separate guidelines on analgesia and sedation for pediatric ICU patients.
This version of the guidelines places a greater emphasis on the psychometric aspects of PAD monitoring tools. It includes both pharmacologic and nonpharmacologic approaches to manage PAD in ICU patients. There is also greater emphasis placed on preventing, diagnosing, and treating delirium, reflecting our growing understanding of this disease process in critically ill patients. These guidelines are meant to help clinicians take a more integrated approach to manage PAD in critically ill patients. Clinicians should adapt these guidelines to the context of individual patient care needs and the available resources of their lo-
